{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:00:55Z","timestamp":1792101655668,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974131"],"award-info":[{"award-number":["81974131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.neuint.2024.105787","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T15:11:04Z","timestamp":1717254664000},"page":"105787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["IL-17A enhances the inflammatory response of glaucoma through Act1\/TRAF6\/NF-\u03baB pathway"],"prefix":"10.1016","volume":"178","author":[{"given":"Yunfan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenni","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neuint.2024.105787_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"issue":"7","key":"10.1016\/j.neuint.2024.105787_bib2","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1161\/STROKEAHA.117.016753","article-title":"CCR6 (CC chemokine receptor 6) is essential for the migration of detrimental natural interleukin-17-producing \u03b3\u03b4 T cells in stroke","volume":"48","author":"Arunachalam","year":"2017","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.neuint.2024.105787_bib3","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1007\/s12035-023-03535-0","article-title":"Anti-inflammatory effects of siponimod in a mouse model of excitotoxicity-induced retinal injury","volume":"60","author":"Basavarajappa","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2024.105787_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.preteyeres.2013.02.003","article-title":"Does autoimmunity play a part in the pathogenesis of glaucoma?","volume":"36","author":"Bell","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"issue":"5","key":"10.1016\/j.neuint.2024.105787_bib5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/rheumatology\/key375","article-title":"Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study","volume":"58","author":"Braun","year":"2019","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.neuint.2024.105787_bib6","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","year":"2021","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.neuint.2024.105787_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102911","article-title":"Fullerol rescues the light-induced retinal damage by modulating M\u00fcller glia cell fate","volume":"67","author":"Cha","year":"2023","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.neuint.2024.105787_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1461145711000149","article-title":"Increased NF-\u03baB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease","volume":"15","author":"Chen","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.neuint.2024.105787_bib9","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202202056RR","article-title":"Interleukin-17A modulates retinal inflammation by regulating microglial activation via the p38 MAPK pathway in experimental glaucoma neuropathy","volume":"37","author":"Chen","year":"2023","journal-title":"Faseb. J."},{"issue":"1","key":"10.1016\/j.neuint.2024.105787_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12967-022-03842-5","article-title":"Angiotensin-(1-7) ameliorates sepsis-induced cardiomyopathy by alleviating inflammatory response and mitochondrial damage through the NF-\u03baB and MAPK pathways","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neuint.2024.105787_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2023.1053877","article-title":"Enriched environment promotes post-stroke angiogenesis through astrocytic interleukin-17A","volume":"17","author":"Chen","year":"2023","journal-title":"Front. Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.neuint.2024.105787_bib12","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.bbrc.2018.08.034","article-title":"Inhibition of TRAF6 alleviates choroidal neovascularization in vivo","volume":"503","author":"Ding","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.neuint.2024.105787_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12974-022-02446-6","article-title":"The role of Th17 cells\/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A","volume":"19","author":"Fu","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.neuint.2024.105787_bib14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.neuint.2024.105787_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102535","article-title":"Glaucoma is an autoimmune disease","volume":"19","author":"Geyer","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"707","key":"10.1016\/j.neuint.2024.105787_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg1656","article-title":"Gut-licensed \u03b27(+) CD4(+) T cells contribute to progressive retinal ganglion cell damage in glaucoma","volume":"15","author":"He","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuint.2024.105787_bib17","article-title":"A magnetic microbead occlusion model to induce ocular hypertension-dependent glaucoma in mice","volume":"109","author":"Ito","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"2","key":"10.1016\/j.neuint.2024.105787_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"issue":"10414","key":"10.1016\/j.neuint.2024.105787_bib19","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","article-title":"Glaucoma: now and beyond","volume":"402","author":"Jayaram","year":"2023","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.neuint.2024.105787_bib20","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1167\/iovs.08-3144","article-title":"Complex antibody profile changes in an experimental autoimmune glaucoma animal model","volume":"50","author":"Joachim","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.neuint.2024.105787_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0098-2997(93)90004-W","article-title":"Potential involvement of the transcription factor NF-kappa B in neurological disorders","volume":"14","author":"Kaltschmidt","year":"1993","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.neuint.2024.105787_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2014.09.003","article-title":"Neutralizing IL-17 protects the optic nerve from autoimmune pathology and prevents retinal nerve fiber layer atrophy during experimental autoimmune encephalomyelitis","volume":"56","author":"Knier","year":"2015","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.neuint.2024.105787_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","article-title":"IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis","volume":"130","author":"Krueger","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.neuint.2024.105787_bib24","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"Mcgeachy","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.neuint.2024.105787_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3899\/jrheum.161238","article-title":"CNTO6785, a fully human antiinterleukin 17 monoclonal antibody, in patients with rheumatoid arthritis with inadequate response to methotrexate: a randomized, placebo-controlled, phase II, dose-ranging study","volume":"45","author":"Mease","year":"2018","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.neuint.2024.105787_bib26","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1080\/21655979.2021.1980645","article-title":"Knockdown of Tripartite motif-containing 22 (TRIM22)relieved the apoptosis of lens epithelial cells by suppressing the expression of TNF receptor-associated factor 6 (TRAF6)","volume":"12","author":"Meng","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.neuint.2024.105787_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2023.101169","article-title":"Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma","volume":"93","author":"Miao","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"issue":"8","key":"10.1016\/j.neuint.2024.105787_bib28","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1167\/iovs.08-3267","article-title":"Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas","volume":"50","author":"Nadal-Nicol\u00e1s","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.neuint.2024.105787_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/iovs.61.10.31","article-title":"Autophagy in the aging and experimental ocular hypertensive mouse model","volume":"61","author":"Nettesheim","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuint.2024.105787_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.629306","article-title":"High ambient temperature aggravates experimental autoimmune uveitis symptoms","volume":"9","author":"Pan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuint.2024.105787_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100799","article-title":"Inducible rodent models of glaucoma","volume":"75","author":"Pang","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"issue":"2","key":"10.1016\/j.neuint.2024.105787_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaad.2018.03.037","article-title":"Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial","volume":"79","author":"Papp","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"12","key":"10.1016\/j.neuint.2024.105787_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126715","article-title":"High-mobility group box 1 inhibitor BoxA alleviates neuroinflammation-induced retinal ganglion cell damage in traumatic optic neuropathy","volume":"23","author":"Peng","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuint.2024.105787_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni1439","article-title":"The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease","volume":"8","author":"Qian","year":"2007","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.neuint.2024.105787_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.117","article-title":"IL-17A exacerbates diabetic retinopathy by impairing M\u00fcller cell function via Act1 signaling","volume":"48","author":"Qiu","year":"2016","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.neuint.2024.105787_bib36","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41419-021-04350-y","article-title":"IL-17A injury to retinal ganglion cells is mediated by retinal M\u00fcller cells in diabetic retinopathy","volume":"12","author":"Qiu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.neuint.2024.105787_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1350-9462(98)00014-7","article-title":"Neuronal death in glaucoma","volume":"18","author":"Quigley","year":"1999","journal-title":"Prog. Retin. Eye Res."},{"issue":"10","key":"10.1016\/j.neuint.2024.105787_bib38","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/1440-1681.13141","article-title":"Th17 cells in glaucoma patients promote Ig production in IL-17A and IL-21-dependent manner","volume":"46","author":"Ren","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neuint.2024.105787_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108826","article-title":"CHOP deletion and anti-neuroinflammation treatment with hesperidin synergistically attenuate NMDA retinal injury in mice","volume":"213","author":"Sato","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.neuint.2024.105787_bib40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1350-9462(00)00024-0","article-title":"Development of retinal ganglion cell structure and function","volume":"20","author":"Sernagor","year":"2001","journal-title":"Prog. Retin. Eye Res."},{"issue":"10","key":"10.1016\/j.neuint.2024.105787_bib41","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","article-title":"Role of nuclear factor kappa B (NF-\u03baB) signalling in neurodegenerative diseases: an mechanistic approach","volume":"18","author":"Singh","year":"2020","journal-title":"Curr. Neuropharmacol."},{"issue":"20","key":"10.1016\/j.neuint.2024.105787_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207442","article-title":"Plasma rich in growth factors enhances cell survival after in situ retinal degeneration","volume":"21","author":"Su\u00e1rez-Barrio","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.neuint.2024.105787_bib43","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/ATVBAHA.115.307080","article-title":"Inhibition of the nuclear receptor ROR\u03b3 and interleukin-17a suppresses neovascular retinopathy: involvement of immunocompetent microglia","volume":"36","author":"Talia","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.neuint.2024.105787_bib44","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.neuint.2024.105787_bib45","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group","volume":"126","year":"1998","journal-title":"Am. J. Ophthalmol."},{"issue":"17","key":"10.1016\/j.neuint.2024.105787_bib46","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.7150\/thno.60031","article-title":"Astrocytic YAP protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model through TGF-\u03b2 signaling","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.neuint.2024.105787_bib47","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bjo.78.8.643","article-title":"Deformation of the lamina cribrosa by elevated intraocular pressure","volume":"78","author":"Yan","year":"1994","journal-title":"Br. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.neuint.2024.105787_bib48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1350-9462(03)00026-0","article-title":"Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma","volume":"22","author":"Y\u00fcCEL","year":"2003","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.neuint.2024.105787_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100866","article-title":"Activation of the interleukin-23\/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis","volume":"80","author":"Zhong","year":"2021","journal-title":"Prog. Retin. Eye Res."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018624001141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018624001141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T23:27:24Z","timestamp":1722468444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018624001141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":49,"alternative-id":["S0197018624001141"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2024.105787","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-17A enhances the inflammatory response of glaucoma through Act1\/TRAF6\/NF-\u03baB pathway","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2024.105787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105787"}}